Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Current Leases (2021 - 2026)

Zymeworks (ZYME) posted Current Leases of $3.3 million for Q1 2026, down 5.53% sequentially from $3.5 million in Q4 2025, and up 0.64% YoY from $3.3 million in Q1 2025.

Analysis

Zymeworks (ZYME) Current Leases (2021 - 2026) Analysis & Trends

Zymeworks has reported Current Leases for 6 years, with the latest figure at $3.3 million in Q1 2026.

  • Quarterly Current Leases rose 0.64% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 0.64% YoY) and the FY2025 annual result came in at $3.5 million, up 26.68% from the prior year.
  • Current Leases retreated to $3.3 million in Q1 2026 per ZYME's latest filing, from $3.5 million in the prior quarter.
  • Over five years, Current Leases peaked at $4.6 million in Q3 2022 and troughed at $2.7 million in Q4 2024.
  • A 5-year average of $3.5 million and a median of $3.4 million in 2025 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2022 and 2024: Current Leases soared 153.59% in 2022, then sank 35.7% in 2024.
  • Over 5 years, Current Leases stood at $3.3 million in 2022, then advanced by 28.27% to $4.3 million in 2023, then plunged by 35.7% to $2.7 million in 2024, then rose by 26.68% to $3.5 million in 2025, then slipped by 5.53% to $3.3 million in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $3.3 million, $3.5 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Zymeworks 2.13 Bn 1.86 Bn - 3.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.30 Mn
Mar 31, 2026 3.28 Mn
Dec 31, 2025 3.47 Mn
Sep 30, 2025 3.40 Mn
Jun 30, 2025 3.59 Mn
Mar 31, 2025 3.26 Mn
Dec 31, 2024 2.74 Mn
Sep 30, 2024 2.94 Mn
Jun 30, 2024 2.84 Mn
Mar 31, 2024 4.16 Mn
Dec 31, 2023 4.26 Mn
Sep 30, 2023 3.84 Mn
Jun 30, 2023 3.65 Mn
Mar 31, 2023 3.37 Mn
Dec 31, 2022 3.32 Mn
Sep 30, 2022 4.61 Mn
Dec 31, 2021 1.31 Mn